Welcome to Our Family

MPP formally opened its doors in 2016. The facility is a modern, fully functional site dedicated to the development of injectable drug products in compliance with current Good Manufacturing Practices (cGMP). The 35,000 sq. ft. campus includes five laboratories outfitted with qualified and validated instrumentation, along with more than 12,000 sq. ft. of available space designated for future expansion into sterile manufacturing.

MPP Group was established to meet the growing demand for pharmaceutical services and products focused on bringing therapies closer to the patient. The company specializes in the development and formulation of injectable drug products, supporting both internal pipeline efforts and contract development for third parties.

With state-of-the-art equipment in both analytical and formulation departments, MPP is equipped to perform a comprehensive range of analytical testing to support drug product development.

The team has played a role in the development of multiple injectable drug candidates, including a product that received regulatory approval and has been commercially available since 2016.

MPP extends its appreciation to colleagues, partners, and customers across the pharmaceutical industry for their continued support and trust.

Thank you for visiting our website. We look forward to working with you.